SCHEMBL30835166

SCHEMBL30835166

CC1CCCc2cc(O)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 11/20 0.55
ESR2 Q92731 10/20 0.55
HSD17B1 P14061 2/20 0.45
SHBG P04278 2/20 0.44
SIGMAR1 Q99720 1/20 0.44
CYP19A1 P11511 2/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
PRKCI P41743 1/20 0.41
HSD17B10 Q99714 3/20 0.40
LMNA P02545 2/20 0.40
CYP1A2 P05177 2/20 0.40
STS P08842 2/20 0.40
HIF1A Q16665 2/20 0.40
AKR1B10 O60218 1/20 0.40
PGR P06401 1/20 0.40
SERPINA6 P08185 1/20 0.40
CYP3A4 P08684 1/20 0.40
AR P10275 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12401916 1.00 ESR1 (0.55) ESR1ESR2HSD17B1SHBGSIGMAR1
SCHEMBL16527048 0.95 ESR1 (0.58) ESR1ESR2HSD17B1SHBGSIGMAR1
SCHEMBL13049833 0.89 ESR1 (0.53) ESR1ESR2HSD17B1SHBGCYP19A1
SCHEMBL8034552 0.89 ESR1 (0.53) ESR1ESR2HSD17B1SHBGCYP19A1
SCHEMBL4981817 0.85 ESR1 (0.46) ESR1ESR2CYP19A1MAOAMAOB
SCHEMBL15577013 0.81 HTR2C (0.58) ESR1ESR2SLC6A4HTR2BTSHR
SCHEMBL19302170 0.81 HTR2C (0.58) ESR1ESR2SLC6A4HTR2BTSHR
SCHEMBL18468830 0.81 HTR2C (0.58) ESR1ESR2SLC6A4HTR2BTSHR
SCHEMBL7913405 0.79 ESR2 (0.57) ESR1ESR2HSD17B1SHBGSIGMAR1
SCHEMBL6902991 0.79 SRD5A1 (0.42) ESR1ESR2LMNASLC6A4HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118451066-A 3-Phenyl-1-benzothiophene-2-carboxylic acid derivatives as inhibitors of branched alpha ketoacid dehydrogenase kinase for the treatment of diabetes, kidney disease, NASH and heart failure 辉瑞大药厂 2024-08-06 CN disclosed
WO-2024125600-A1 HETEROCYCLIC COMPOUNDS ACTING AS KRAS INHIBITORS, PREPARATION THEREFOR AND THERAPEUTIC USE THEREOF 上海科州药物研发有限公司 2024-06-20 WO disclosed
CN-117813306-A Heterocyclic compounds as KRAS inhibitors, their preparation and therapeutic use 上海科州药物研发有限公司 2024-04-02 CN disclosed